BridgeMD
New treatment option for Lipid Metabolism Disorders
Official title Effect of Ilex Paraguariensis Harvest Time and Consumption Method of Processed Yerba Mate on the Lipid Profile
ClinicalTrials.gov ID: NCT06896175
What this study is testing
- What it's testing
- Introduction: This project studies the impact of Ilex paraguariensis harvest time, commonly known as yerba mate, and its consumption mode (mate, tereré, and mate/terere) on the lipid profile of consumers in the Department of Caaguazú, Paraguay. Yerba mate is rich in bioactive compounds such as polyphenols, xanthines, and saponins.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Individuals of both sexes, between 18 and 60 years of age, residing in the country, who consume prepared yerba mate.
- Consumers of mate or tereré and mate/terere who agree to consume the yerba mate samples provided by the research team, which will be masked from...
- Two weeks of abstinence from consuming prepared yerba mate, either as mate or tereré, prior to randomization for the trial.
- Consume exclusively prepared yerba mate in the prescribed manner (quantity of yerba, frequency of consumption, and sips), either in its mate or...
- Do not change the yerba mate consumer's usual diet or regular physical activity during the trial period.
You likely can't join if
- Individuals receiving lipid-lowering treatment at the start of the trial.
- Consuming any other type of yerba mate not provided by the principal investigator.
- Individuals requiring vitamins as a nutritional supplement.
- Individuals taking thermogenic supplements.
- Individuals consuming cooked mate.
- Addiction to medicinal plants or herbs, both mate and tereré.
See the full eligibility criteria
- Individuals of both sexes, between 18 and 60 years of age, residing in the country, who consume prepared yerba mate.
- Consumers of mate or tereré and mate/terere who agree to consume the yerba mate samples provided by the research team, which will be masked from laboratory analysis.
- Two weeks of abstinence from consuming prepared yerba mate, either as mate or tereré, prior to randomization for the trial.
- Consume exclusively prepared yerba mate in the prescribed manner (quantity of yerba, frequency of consumption, and sips), either in its mate or tereré form independently, and for those who consume both forms daily.
- Do not change the yerba mate consumer's usual diet or regular physical activity during the trial period.
- Agree to know the laboratory results of the lipid profile only at the end of the trial (180 days after the start).
- Individuals receiving lipid-lowering treatment at the start of the trial.
- Consuming any other type of yerba mate not provided by the principal investigator.
- Individuals requiring vitamins as a nutritional supplement.
- Individuals taking thermogenic supplements.
- Individuals consuming cooked mate.
- Addiction to medicinal plants or herbs, both mate and tereré.
- Individuals with a personal history of coronary artery disease.
The study team makes the final eligibility decision.
Where it's taking place
- Coronel Oviedo, Paraguay
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Coronel Oviedo, Paraguay. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.